Pharmacogenetics and Genomics : Impact Factor & More
eISSN: 1744-6880pISSN: 1744-6872
Share this on:
Key Metrics
CiteScore 
4.5
Impact Factor
< 5
SJR
Q2Genetics
SNIP
0.65
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Pharmacogenetics and Genomics
Pharmacogenetics and Genomics Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmacogenetics and Genomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Pharmacogenetics and Genomics
Knowledge and perspectives on pharmacogenomic-guided antidepressant treatment among psychiatrists and primary care practitioners.
- 1 Sep 2026
- Pharmacogenetics and genomics
The role of pro-inflammatory cytokine gene polymorphisms in major depressive disorder: a systematic review.
- 1 Sep 2026
- Pharmacogenetics and genomics
The HTR2A rs6311 and rs6313 polymorphisms and atypical antipsychotics response in schizophrenia: a scoping review.
- 1 Sep 2026
- Pharmacogenetics and genomics
DPYD polymorphisms in Native populations from the Brazilian Amazon: the absence of the variants in currently recommended clinical genotyping panels.
- 1 Sep 2026
- Pharmacogenetics and genomics
Prevalence of CYP2C19 phenotypes in patients undergoing a hiatal hernia repair.
- 1 Sep 2026
- Pharmacogenetics and genomics
Low expression of ZFP36L2 causes glucocorticoid resistance in childhood T-cell acute lymphoblastic leukemia.
- 1 Sep 2026
- Pharmacogenetics and genomics
Knowledge and perspectives on pharmacogenomic-guided antidepressant treatment among psychiatrists and primary care practitioners.
- 1 Sep 2026
- Pharmacogenetics and genomics
The role of pro-inflammatory cytokine gene polymorphisms in major depressive disorder: a systematic review.
- 1 Sep 2026
- Pharmacogenetics and genomics
The HTR2A rs6311 and rs6313 polymorphisms and atypical antipsychotics response in schizophrenia: a scoping review.
- 1 Sep 2026
- Pharmacogenetics and genomics
DPYD polymorphisms in Native populations from the Brazilian Amazon: the absence of the variants in currently recommended clinical genotyping panels.
- 1 Sep 2026
- Pharmacogenetics and genomics
Prevalence of CYP2C19 phenotypes in patients undergoing a hiatal hernia repair.
- 1 Sep 2026
- Pharmacogenetics and genomics
Low expression of ZFP36L2 causes glucocorticoid resistance in childhood T-cell acute lymphoblastic leukemia.
- 1 Sep 2026
- Pharmacogenetics and genomics
FAQs on Pharmacogenetics and Genomics
How long has Pharmacogenetics and Genomics been actively publishing? 
What is the publishing frequency of Pharmacogenetics and Genomics?
How many articles did Pharmacogenetics and Genomics publish last year?
What is the eISSN & pISSN for Pharmacogenetics and Genomics?
What is Citescore for Pharmacogenetics and Genomics?
What is SNIP score for Pharmacogenetics and Genomics?
What is the SJR for Pharmacogenetics and Genomics?
Who is the publisher of Pharmacogenetics and Genomics?
